A phase I, single-center, open-label, two-period, two-treatment, fixed-sequence crossover study investigating the impact repeated doses of pantoprazole on the pharmacokinetic (PK) properties of fedratinib in healthy male subjects
Latest Information Update: 03 Dec 2020
At a glance
- Drugs Fedratinib (Primary) ; Ondansetron; Pantoprazole
- Indications Myelofibrosis
- Focus Pharmacokinetics
- 03 Dec 2020 New trial record